Bristol Myers

Bristol Myers Squibb is a global biopharmaceutical company that develops, manufactures, and sells prescription medicines for serious diseases, with a significant focus on cancer treatments.

Why it’s in the news: It is in the news due to potential merger discussions with AstraZeneca and its major investments in AI technology for drug research and procurement.

Latest on Bristol Myers

• An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’
• AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
• STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
• Bristol Myers buys Nvidia's latest AI computing system for drug research
• Inside Bristol Myers’ AI-powered procurement overhaul

Connections

2 entities linked to Bristol Myers across the news graph.